FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

768504002: Product containing glimepiride and rosiglitazone in oral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3710152012 Glimepiride- and rosiglitazone-containing product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3710153019 Product containing glimepiride and rosiglitazone in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


6 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Glimepiride- and rosiglitazone-containing product in oral dose form a une forme pharmaceutique (attribut) forme orale true Inferred relationship Some
Glimepiride- and rosiglitazone-containing product in oral dose form a pour principe actif (attribut) Rosiglitazone (substance) true Inferred relationship Some 2
Glimepiride- and rosiglitazone-containing product in oral dose form est un(e) (attribut) Product containing glimepiride in oral dose form (medicinal product form) true Inferred relationship Some
Glimepiride- and rosiglitazone-containing product in oral dose form est un(e) (attribut) Product containing rosiglitazone in oral dose form (medicinal product form) true Inferred relationship Some
Glimepiride- and rosiglitazone-containing product in oral dose form est un(e) (attribut) Product containing glimepiride and rosiglitazone (medicinal product) true Inferred relationship Some
Glimepiride- and rosiglitazone-containing product in oral dose form a pour principe actif (attribut) Glimepiride (substance) true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group
Glimepiride and rosiglitazone only product in oral dose form est un(e) (attribut) True Glimepiride- and rosiglitazone-containing product in oral dose form Inferred relationship Some
Glimepiride 4 mg and rosiglitazone maleate 4 mg oral tablet est un(e) (attribut) False Glimepiride- and rosiglitazone-containing product in oral dose form Inferred relationship Some
Product containing precisely glimepiride 2 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) False Glimepiride- and rosiglitazone-containing product in oral dose form Inferred relationship Some
Glimepiride 4 mg and rosiglitazone 8 mg oral tablet est un(e) (attribut) False Glimepiride- and rosiglitazone-containing product in oral dose form Inferred relationship Some
Glimepiride 2 mg and rosiglitazone 8 mg oral tablet est un(e) (attribut) False Glimepiride- and rosiglitazone-containing product in oral dose form Inferred relationship Some
Product containing precisely glimepiride 1 milligram and rosiglitazone maleate 4 milligram/1 each conventional release oral tablet (clinical drug) est un(e) (attribut) False Glimepiride- and rosiglitazone-containing product in oral dose form Inferred relationship Some

This concept is not in any reference sets

Back to Start